Interestingly, the IGF1/IGFBP3 ratio in HCC patients was significantly higher than in both cirrhotic patients and controls, suggesting that HCC could be associated with an increased IGF1 bioavailability[101]. This evidence concerns the gene IGF1 and hepatocellular carcinoma.